Daftar untuk membuat makluman bagi Instrumen,
Acara Ekonomi dan kandungan berdasarkan penulis yang diikuti
Daftar Percuma Sudah mempunyai akaun? Daftar Masuk
Sebutan
Semua Jenis Instrumen
- Semua Jenis Instrumen
- Indeks
- Ekuiti
- ETF
- Dana
- Komoditi
- Matawang
- Kripto
- Bon
- Sijil
Sila cuba carian lain
Baharu! 💥 Dapatkan ProPicks untuk lihat strategi yang telah atasi S&P 500 sebanyak 1,183%+ Tuntut 40% POTONGAN
Marksans Pharma Ltd (MARK)
Tambah kepada/Keluarkan daripada Portfolio
Tambah kepada Portfolio
172.00
+4.85
+2.90%
- Volum: 2,107,130
- Bidaan/Permintaan: 171.40 / 172.00
- Julat Hari: 166.15 - 173.80
Marksans Pharma Ltd
172.00
+4.85
+2.90%
- Perbincangan
- Sentimen Terkini
- Penarafan Pengguna
Penarafan Pengguna MARK
Di laman ini, pengguna ditarafkan berdasarkan prestasi sentimen mereka bagi saham Marksans Pharma Ltd.
| Penarafan | Kata Nama | Jumlah | Ditutup | Kemenangan | Menang % | Prbhn. % |
|---|---|---|---|---|---|---|
| 1 | Pradeep Kumar Mittal | 2 | 2 | 2 | 100 | +92.14% |
| 2 | Dhiraj Sharma | 1 | 1 | 1 | 100 | +53.29% |
| 3 | KIRAN DUBALE | 1 | 1 | 1 | 100 | +51.4% |
| 4 | Harshad Mondkar | 2 | 2 | 2 | 100 | +50.4% |
| 5 | Suresh Ravesh | 1 | 1 | 1 | 100 | +49.05% |
| 6 | Vishal Pandit | 1 | 1 | 1 | 100 | +42.41% |
| 7 | Harish Madlani | 2 | 2 | 2 | 100 | +42.16% |
| 8 | Santosh Kumar | 1 | 1 | 1 | 100 | +34.63% |
| 9 | NIKHIL VERNEKAR | 1 | 1 | 1 | 100 | +33.59% |
| 10 | nagesh tikare | 1 | 1 | 1 | 100 | +23.64% |
| 11 | MHoque Mubin | 1 | 1 | 1 | 100 | +19.27% |
| 12 | Kapil Tiwari | 1 | 1 | 1 | 100 | +17.71% |
| 13 | Kckswamy Swamy | 1 | 1 | 1 | 100 | +14.91% |
| 14 | Nitesh Ambavle | 1 | 1 | 1 | 100 | +14.23% |
| 15 | Ganesh Ram | 1 | 1 | 1 | 100 | +12.58% |
| 16 | TAJU NEGI | 1 | 1 | 1 | 100 | +11.09% |
| 17 | Parteek Panwar | 1 | 1 | 1 | 100 | +10.08% |
| 18 | grey color | 1 | 1 | 1 | 100 | +9.94% |
| 19 | rajesh kumar | 1 | 1 | 1 | 100 | +9.52% |
| 20 | Subrat Sahu | 1 | 1 | 1 | 100 | +9.52% |
| 21 | Dharmesh Sharma | 1 | 1 | 1 | 100 | +7.61% |
| 22 | Suvojit Laha | 1 | 1 | 1 | 100 | +5.41% |
| 23 | Arpita Ghosh | 1 | 1 | 1 | 100 | +3.85% |
| 24 | patadiya amit | 1 | 1 | 1 | 100 | +2.04% |
| 25 | Sameer Kumar | 1 | 0 | 0 | 0 | +1.79% |
| 26 | Aditya Kispotta | 1 | 1 | 1 | 100 | +1.35% |
| 27 | vinay chalakh | 1 | 1 | 1 | 100 | +0.88% |
| 28 | Ganesh Joshi | 1 | 1 | 1 | 100 | +0.29% |
| 29 | Amit Shingte | 1 | 1 | 0 | 0 | 0% |
| 30 | Balamurugesh Vellaisamy | 1 | 1 | 0 | 0 | -3.3% |
| 31 | T. C. Sundaresan | 1 | 1 | 0 | 0 | -3.57% |
| 32 | Santosh Killekar | 1 | 1 | 0 | 0 | -3.86% |
| 33 | Murlidhar Wakode | 1 | 1 | 0 | 0 | -5.31% |
| 34 | vipin jain | 1 | 1 | 0 | 0 | -5.4% |
| 35 | Sushil Verma | 1 | 1 | 0 | 0 | -7.26% |
| 36 | Senthil Balasubramaniam | 1 | 1 | 0 | 0 | -7.38% |
| 37 | TECHNICAL GURUJI | 1 | 0 | 0 | 0 | -8.36% |
| 38 | brijendra goyal | 1 | 1 | 0 | 0 | -8.55% |
| 39 | Bhole Khanna | 1 | 1 | 0 | 0 | -9.33% |
| 40 | Sanjay Safiwala | 1 | 1 | 0 | 0 | -11.49% |
| 41 | Dinesh Yuvan | 1 | 1 | 0 | 0 | -11.76% |
| 42 | Jason Tauro | 1 | 1 | 0 | 0 | -14.38% |
| 43 | Balakrishnan Karthik | 1 | 1 | 0 | 0 | -15.58% |
| 44 | Amit Ghanghoria | 1 | 1 | 0 | 0 | -17.1% |
| 45 | Kedarnath Uchekar | 1 | 1 | 0 | 0 | -17.18% |
| 46 | SUMIT KUMAR | 1 | 1 | 0 | 0 | -17.51% |
| 47 | jignesh mistry | 4 | 4 | 1 | 25 | -20.7% |
| 48 | tarun chopra | 2 | 2 | 0 | 0 | -23.84% |
| 49 | Aftab Seikh | 2 | 2 | 1 | 50 | -28.2% |
| 50 | Vicky Karmakar | 1 | 1 | 0 | 0 | -43.36% |
Tulis pendapat anda tentang Marksans Pharma Ltd
Adakah anda pasti anda mahu padamkan carta ini?
Padam Batal
Gantikan carta yang disertakan dengan carta baru?
Ganti Batal
Garis Panduan Komen
Tambah Carta kepada Komen
Sahkan Halangan
Adakah anda pasti anda mahu halang %USER_NAME%?
Dengan berbuat demikian, anda dan %USER_NAME% tidak akan dapat melihat post satu sama lain.
%USER_NAME% telah berjaya ditambah ke Senarai Halangan anda
Oleh kerana anda baru sahaja berhenti halang orang ini, anda perlu menunggu 48 jam sebelum memperbaharui halangan itu.
Laporkan komen ini
Saya berpendapat komen ini:
Komen ditandakan
Thank You!
Laporan anda telah dihantar kepada moderator untuk semakan